Related Experiment Video
Updated: Jan 9, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.5K
[Clinical molecular genetics for PARK8 (LRRK2)]
Hiroyuki Tomiyama1, Taku Hatano, Nobutaka Hattori
1Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|August 24, 2007
Summary
Parkinson's disease (PD) involves genetic and environmental factors. Mutations in the LRRK2 gene are a significant cause of familial PD, influencing disease pathways and pathology.
Area of Science:
- Neurogenetics
- Molecular Neurology
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) is the second most common neurodegenerative disorder.
- While most PD cases are sporadic, 5-10% are familial (FPD), often linked to genetic factors.
- The LRRK2 gene, identified in 2004, is a key player in autosomal dominant PD (ADPD).
Purpose of the Study:
- To explore the role of LRRK2 mutations in Parkinson's disease pathogenesis.
- To understand the genetic distribution and clinical variability associated with LRRK2 mutations.
- To investigate the intersection of LRRK2 with other PD-related proteins and pathways.
Main Methods:
- Genetic analysis of familial and sporadic Parkinson's disease cases.
- Clinical assessment of patients with identified LRRK2 mutations.
- Review of existing literature on LRRK2 function, pathology, and interactions.
Main Results:
- LRRK2 mutations are found in 2-13% of ADPD and 0.5-3% of sporadic PD cases globally.
- Specific variants like G2019S, R1441G, and G2385R show ethnic variations, with G2385R being a risk factor in Asia.
- Patients exhibit diverse clinical and pathological features, sometimes lacking Lewy bodies, suggesting LRRK2's complex role.
Conclusions:
- LRRK2 is a critical gene in familial Parkinson's disease, contributing to diverse clinical presentations.
- The protein's multifunctionality, including alpha-synuclein and tau phosphorylation, is implicated in PD pathology.
- Interactions between LRRK2 and other PD proteins highlight common pathways in neurodegeneration.
